A positive feedback loop between SERPINH1 and MMP-9/TGF-β1 promotes lung adenocarcinoma progression
- PMID: 40819105
- DOI: 10.1038/s41418-025-01558-9
A positive feedback loop between SERPINH1 and MMP-9/TGF-β1 promotes lung adenocarcinoma progression
Abstract
Lung adenocarcinoma (LUAD), the most predominant subtype of lung cancer, is a leading cause of cancer-related death worldwide. However, its underlying molecular mechanisms remain poorly understood. In this study, we identified that SERPINH1, a member of the serine protease inhibitor (serpin) superfamily, is upregulated in LUAD tissues and cells. Furthermore, high expression of SERPINH1 is associated with poor prognosis in patients. Functional experiments revealed that overexpression of SERPINH1 promotes the proliferation, invasion, and migration of LUAD cells. Further investigation showed that MMP-9 is a novel binding partner of SERPINH1. SERPINH1 enhances the protein levels of MMP-9 by inhibiting its ubiquitination, which in turn promotes the activation and secretion of extracellular TGF-β1, leading to the activation of cancer-associated fibroblasts (CAFs). Additionally, the sustained activation of TGF-β signaling further enhances the transcription of SERPINH1, establishing a positive feedback loop between SERPINH1 and TGF-β1. Taken together, our findings suggest that the SERPINH1/TGF-β1 positive feedback loop plays a crucial role in the onset and metastasis of LUAD. SERPINH1 may serve as a potential prognostic and therapeutic target in LUAD.
© 2025. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The collection and use of human tissue samples were approved by the Ethics Committee of Harbin Medical University Cancer Hospital, and informed consent was obtained from all patients prior to participation. All animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Ethics Committee of Harbin Medical University.
Similar articles
-
SKA3 promotes lung adenocarcinoma progression via the EGFR/E2F1/SKA3/integrin β1 signaling loop.Mol Cell Biochem. 2025 Jul;480(7):4213-4226. doi: 10.1007/s11010-025-05242-x. Epub 2025 Mar 8. Mol Cell Biochem. 2025. PMID: 40056339
-
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8. Sci Rep. 2025. PMID: 40594106 Free PMC article.
-
KDELR3 is transcriptionally activated by FOXM1 and accelerates lung adenocarcinoma growth and metastasis via inhibiting endoplasmic reticulum stress-induced cell apoptosis.Hum Cell. 2025 May 24;38(4):106. doi: 10.1007/s13577-025-01238-3. Hum Cell. 2025. PMID: 40411680
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Systematic Review of the Differential Effects of TGF-β1 in Ischemic and Hemorrhagic Preclinical Stroke Models.J Am Heart Assoc. 2025 Jul 15;14(14):e037890. doi: 10.1161/JAHA.124.037890. Epub 2025 Jul 1. J Am Heart Assoc. 2025. PMID: 40590572
References
-
- Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535–54. - PubMed
-
- Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. - PubMed
-
- Seguin L, Durandy M, Feral CC. Lung adenocarcinoma tumor origin: a guide for personalized medicine. Cancers (Basel). 2022;14:1759. - PubMed
-
- Bai Q, Wang J, Zhou X. EGFR exon20 insertion mutations in non-small cell lung cancer: Clinical implications and recent advances in targeted therapies. Cancer Treat Rev. 2023;120:102605. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous